INSTITUTION'S PROFILE

UCB Pharma, Slough, UK.

Publications (1)

Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trials.

Journal: Journal of the American Academy of Dermatology

Publication date: 

Journal: Journal of the American Academy of Dermatology

Publication Year: 

Authors & Co-authors:  Blauvelt Armstrong Merola Strober de Cuyper Peterson Davies Stark Lebwohl